top of page

Nevro Corp (NVRO) entered into a Cooperation Agreement with Engaged Capital

Key Summary: On Dec 11, 2023, Engaged Capital (6%) announced ongoing talks with the Board and management to enhance shareholder value. On Feb 21, 2024, a Cooperation Agreement was signed with Engaged Capital, appointing Kirt P. Karros to the Board and Audit Committee effective Feb 20, 2024

Market Cap: $568 million | Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. 

Background


On December 11, 2023, Engaged Capital (6%) stated that it has engaged, and intends to continue to engage, in communications with the Board and management team regarding opportunities to maximize stockholder value. Source

Update

On February 21, 2024, the company entered into a Cooperation Agreement with Engaged Capital pursuant to which Kirt P. Karros has been appointed to the Board as well as the Audit Committee of the Board effective February 20, 2024. Source

2 views0 comments

Recent Posts

See All

תגובות


bottom of page